Please login to the form below
Reig Jofre
This page shows the latest Reig Jofre news and features for those working in and with pharma, biotech and healthcare.
Reig Jofre and LeanBio launch Syna Therapeutics
The new company will focus on the development of biosimilars. Pharmaceutical group Reig Jofre has entered into a strategic alliance with LeanBio, a four-year-old biotech company, to launch a ... Hoping to tap into a global biosimilar market of around 1,
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest appointments
-
Reig Jofre boosts Forté Pharma’s senior team
Appoints Alain Boutboul as the nutritional supplements group’s general manager. Reig Jofre’s nutritional supplement group Forté Pharma has appointed a new general manager in the form of Alain Boutboul. ... Boutboul joined Forté Pharma as one of its
-
Reig Jofre appoints Alejandro Reig as vice president
He previously served as director of the company. Spanish pharmaceutical group Reig Jofre has appointed Alejandro Reig as its new vice president. ... He most recently took the director position at Reig Jofre after its merger with Natraceutical in December
-
Reig Jofre bolsters its senior team
Spanish pharmaceutical group Reig Jofre has promoted Gabriel Zapatero (pictured right) to chief operating officer (COO) from his previous role as chief financial officer (CFO), following almost 15 years’ of service
More from appointments
Approximately 3 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Senior Medical Writer
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- MHRA to introduce new UK clinical trials framework
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- PMGroup announces launch of new recruitment platform PharmaRole
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- BioNTech reveals plans to spend about €1bn more on research and development this year
- AstraZeneca’s mild combination asthma reliever approved in UK
- Virtual Patient Engagement Program: A Customer Story
- Putting Skin in the Game at AAD 2023
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- MHRA to introduce new UK clinical trials framework
- Sanofi/Regeneron’s Dupixent approved by EC for atopic dermatitis in children
- Inizio appoints Stefanie Christmas as global head of DE&I
- The Considered appoints Bam Zahraie as chief experience officer
PMHub
Anthem PR
With a rare strength in media and influencer relations, Anthem’s award-winning team offers a fresh approach to health PR...
Latest intelligence
- Virtual Patient Engagement Program: A Customer Story
- Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
- Humancomms for humancare?
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
